Optimally biosynthesized, PEGylated gold nanoparticles functionalized with quercetin and camptothecin enhance potential anti-inflammatory, anti-cancer and anti-angiogenic activities
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Optimally biosynthesized, PEGylated gold nanoparticles functionalized with quercetin and camptothecin enhance potential anti-inflammatory, anti-cancer and anti-angiogenic activities ; volume:19 ; number:1 ; day:25 ; month:3 ; year:2021 ; pages:1-17 ; date:12.2021
Journal of nanobiotechnology ; 19, Heft 1 (25.3.2021), 1-17, 12.2021
- Creator
-
Sadalage, Priyadarshani S.
Patil, Reshma V.
Havaldar, Darshana V.
Gavade, Shruti S.
Santos, Ana Cláudia
Pawar, Kiran D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12951-021-00836-1
- URN
-
urn:nbn:de:101:1-2021050919583100786896
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sadalage, Priyadarshani S.
- Patil, Reshma V.
- Havaldar, Darshana V.
- Gavade, Shruti S.
- Santos, Ana Cláudia
- Pawar, Kiran D.
- SpringerLink (Online service)
Other Objects (12)
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Anti tumor activity of salvia officinalis is due to its anti-angiogenic, anti-migratory and anti-proliferative effects
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Characterization of the myxobacterial compound Chondramide as novel anti-angiogenic and anti-metastatic agent
Characterization of the myxobacterial compound Chondramide as novel anti-angiogenic and anti-metastatic agent
Biomolecular Interaction, Anti-Cancer and Anti-Angiogenic Properties of Cobalt(III) Schiff Base Complexes
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Anti tumor activity of salvia officinalis is due to its anti-angiogenic, anti-migratory and anti-proliferative effects
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Characterization of the myxobacterial compound Chondramide as novel anti-angiogenic and anti-metastatic agent
Characterization of the myxobacterial compound Chondramide as novel anti-angiogenic and anti-metastatic agent
Biomolecular Interaction, Anti-Cancer and Anti-Angiogenic Properties of Cobalt(III) Schiff Base Complexes
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Anti tumor activity of salvia officinalis is due to its anti-angiogenic, anti-migratory and anti-proliferative effects
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Characterization of the myxobacterial compound Chondramide as novel anti-angiogenic and anti-metastatic agent
Characterization of the myxobacterial compound Chondramide as novel anti-angiogenic and anti-metastatic agent